Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

Anne LaprieSoléakhéna KenThomas FilleronVincent LubranoLaure VieillevigneFatima TensaoutiIsabelle CatalaaSergio BoettoJonathan KhalifaJustine AttalGuillaume PeyragaCarlos Gomez-RocaEmmanuelle Uro-CosteGeorges NoelGilles TrucMarie-Pierre SunyachNicolas MagnéMarie CharissouxStéphane SupiotValérie BernierMuriel MounierMuriel PoublancAmandine FabreJean-Pierre DelordElizabeth Cohen-Jonathan Moyal

Published in: BMC cancer (2019)

NCT01507506 , registration date December 20, 2011.

Keyphrases

phase iii
open label
double blind
newly diagnosed
clinical trial
phase ii
placebo controlled
locally advanced
high resolution
molecular docking
magnetic resonance
magnetic resonance imaging
randomized controlled trial
rectal cancer
radiation therapy
computed tomography
contrast enhanced
fluorescence imaging